P84.15 Alectinib in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer as First-Line or Sequential Treatment in China

X. Yang, X. Dong, Y. Liu,B. Jin,J. Wang,Y. Wang,Y. Zhang, M. Zhuo,J. Zhao

Journal of Thoracic Oncology（2021）

引用 2|浏览2

暂无评分

关键词

Alectinib,Lung cancer,Oncology,Medicine,ALK-Positive,First line,In patient,Internal medicine,Non small cell,Sequential treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要